Docteur ALIX GREDER-BELAN

Bibliographie

• Salvage Therapy Including Foscarnet and Ibalizumab for Multidrug-Resistant Human Immunodeficiency Virus Type 2 Infection

  2024

  ArticleClinical Infectious Diseases

• Outcomes in Patients With COVID-19 With Acute Encephalopathy and Coma

  2023

  ArticleNeurology

• Outcomes in Patients With COVID-19 With Acute Encephalopathy and Coma: An International Prospective Study

  2023

  ArticleNeurology

• A highly virulent variant of HIV-1 circulating in the Netherlands

  2022

  ArticleScience

• A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial

  2022

  ArticleThe Lancet HIV

• Rapid screening of COVID-19 patients using white blood cell scattergrams, a study on 381 patients

  2020

  ArticleBritish Journal of Haematology

Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).

Lieu de consultation

• CH DE VERSAILLES SITE ANDRE MIGNOT

  177 Rue DE VERSAILLES, 78157 Le Chesnay-Rocquencourt

  ☎ 0139639133Hospitalier🏥 Centre CH ↗🏥 Voir cet établissement

Tarifs & secteur de conventionnement

Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).

Prendre rendez-vous & contact

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Top publications · les plus citées

• 1

  Rapid screening of COVID-19 patients using white blood cell scattergrams, a study on 381 patients

  British journal of haematology · 2020

  📚 20 citations🎯 RCR 1.13🔓 Open Access📄 PDF gratuit ↗

  Lire l'abstract Crossref ↓

  SummaryComplementary tools are warranted to increase the sensitivity of the initial testing for COVID‐19. We identified a specific ‘sandglass’ aspect on the white blood cell scattergram of COVID‐19 patients reflecting the presence of circulating plasmacytoid lymphocytes. Patients were dichotomized as COVID‐19‐positive or ‐negative based on reverse transcriptase polymerase chain reaction (RT‐PCR) and chest computed tomography (CT) scan results. Sensitivity and specificity of the ‘sandglass’ aspect were 85·9% and 83·5% respectively. The positive predictive value was 94·3%. Our findings provide a non‐invasive and simple tool to quickly categorize symptomatic patients as either COVID‐19‐probable or ‐improbable especially when RT‐PCR and/or chest CT are not rapidly available.

• 2

  Severe Scabies: A French Multi-centre Study Involving 95 Patients with Crusted and Profuse Disease and Review of the Literature

  Acta dermato-venereologica · 2023

  📚 18 citations🎯 RCR 3.93Top 11% NIH🔓 Open Access📄 PDF gratuit ↗

  Lire l'abstract Crossref ↓

  The aim of this multi-centre French retrospective study was to identify severe, i.e. crusted and profuse, scabies patients. Records were retrieved from 22 Dermatology or Infectious Diseases departments in the Ile-de-France from January 2009 to January 2015 to characterize epidemiology, demography, diagnosis, contributing factors, treatment features, and outcomes in severe scabies. A total of 95 inpatients (57 crusted and 38 profuse) were included. A higher number of cases was observed among elderly patients (>75 years), mostly living in institutions. Thirteen patients (13.6%) reported a history of previously treated scabies. Sixty-three patients (66.3%) had been seen by a previous practitioner for the current episode (up to 8 previous visits). Initial misdiagnosis (e.g. eczema, prurigo, drug-related eruptions, psoriasis) was documented in 41 patients (43.1%). Fifty-eight patients (61%) had already received 1 or more previous treatments for their current episode. Forty percent received corticosteroids or acitretin for an initial diagnosis of eczema or psoriasis. Median time from the onset of symptoms to the diagnosis of severe scabies was 3 months (range 0.3–22). Itch was present in all patients at diagnosis. Most patients (n=84, 88.4%) had comorbidities. Diagnostic and therapeutic approaches varied. Complications occurred in 11.5% of cases. To date, there is no consensus for diagnosis and treatment, and future standardization of is required for optimal management.

• 3

  Primary peritonitis due to Streptococcus pyogenes with reduced susceptibility to fluoroquinolones

  Diagnostic microbiology and infectious disease · 2008

  📚 8 citations

Publications scientifiques (7) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Partager cette fiche